Acadia Pharmaceuticals | ACAD - Lucro Operacional





Lucro Operacional Alterar Data
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
ALKERMES USD 36.59M 102.52M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Cara Therapeutics USD -7.05M 1.11M 2026-03
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Cytokinetics USD -167.09M 12.08M 2026-09
Eisai JPY 24.73B 35.04B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Incyte USD -707.47M 1.41B 2026-09
J&J USD 6.47B 1B 2026-09
Moderna USD 130M 945M 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
Pfizer USD 662M 5M 2026-09
Prothena USD -18.69M 44.48M 2026-06
PTC Therapeutics USD 148.98M 103.09M 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09